Financials

Clorox Company (The) financials

CLX Household Products

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a global leader in consumer products with a focus on cleaning, health, and lifestyle solutions. It is renowned for flagship offerings such as Clorox Disinfecting Wipes and Clorox Clean-Up Cleaner + Bleach, along with a diversified brand portfolio that includes Burt's Bees. Under CEO Benno Dorer’s leadership, Clorox emphasizes innovation, sustainability, and digital transformation. With a strong market share of approximately 15-20% in key segments, the company is well-positioned for continued growth.

Snapshot

Clorox Company (The) reported $7.10B in revenue in fiscal 2025, up 0.2% year over year, with an operating margin of 15.2%.

Revenue (FY2025): $7.10B
YoY growth: +0.2%
Operating margin: 15.2%
Direction: Expanding

Financial statements

In thousands, USD
	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenues	7,104,000	7,093,000	7,389,000	7,107,000
Cost of Sales	3,891,000	4,045,000	4,481,000	4,562,000
Gross Profit	3,213,000	3,048,000	2,908,000	2,545,000
Selling, General & Administrative Expenses	1,894,000	1,999,000	1,917,000	1,663,000
Research & Development Expenses	121,000	126,000	138,000	132,000
Other Operating Expenses	118,000	411,000	445,000	—
Operating Profit	1,080,000	512,000	408,000	750,000
Interest Expense	(88,000)	(90,000)	(90,000)	(106,000)
Non-Operating Income	86,000	(24,000)	(80,000)	(37,000)
Total Non-Operating Income	(2,000)	(114,000)	(170,000)	(143,000)
Income Before Provision for Income Taxes	1,078,000	398,000	238,000	607,000
Provision for Income Taxes	254,000	106,000	77,000	136,000
Consolidated Net Income	824,000	292,000	161,000	471,000
Net Income Attributable to Minority Interests and Other	14,000	12,000	12,000	9,000
Net Income Attributable to Common Shareholders	810,000	280,000	149,000	462,000
Basic EPS	6.56	2.26	1.21	3.75
Diluted EPS	6.52	2.25	1.20	3.73
Basic Weighted Average Shares Outstanding	123,525	124,174	123,589	123,113
Diluted Weighted Average Shares Outstanding	124,287	124,804	124,181	123,906
Shares Outstanding	122,694	124,202	123,820	123,152

In thousands, USD
	FY 2025	FY 2024	FY 2023	FY 2022
Cash and Cash Equivalents	167,000	202,000	367,000	183,000
Total Cash and Cash Equivalents	167,000	202,000	367,000	183,000
Accounts Receivable	821,000	695,000	688,000	681,000
Total Trade Receivables	821,000	695,000	688,000	681,000
Inventories	523,000	637,000	696,000	755,000
Other Current Assets	97,000	88,000	77,000	106,000
Total Current Assets	1,608,000	1,622,000	1,828,000	1,725,000
Net Property, Plant & Equipment	1,600,000	1,675,000	1,691,000	1,676,000
Net Intangible Assets	566,000	681,000	712,000	884,000
Goodwill	1,229,000	1,228,000	1,252,000	1,558,000
Other Long-Term Assets	558,000	545,000	462,000	315,000
Total Assets	5,561,000	5,751,000	5,945,000	6,158,000
Accounts Payable	1,828,000	1,486,000	1,659,000	1,469,000
Short-Term Debt	4,000	4,000	50,000	237,000
Current Portion of Leases	87,000	84,000	87,000	78,000
Other Current Liabilities	—	—	121,000	—
Total Current Liabilities	1,919,000	1,574,000	1,917,000	1,784,000
Long-Term Debt	2,484,000	2,481,000	2,477,000	2,474,000
Leases	305,000	334,000	310,000	314,000
Other Long-Term Liabilities	371,000	870,000	853,000	857,000
Total Long-Term Liabilities	3,160,000	3,685,000	3,640,000	3,645,000
Total Liabilities	5,079,000	5,259,000	5,557,000	5,429,000
Common Stock	131,000	131,000	131,000	131,000
Treasury Stock	(1,404,000)	(1,186,000)	(1,246,000)	(1,346,000)
Additional Paid-in Capital	1,319,000	1,288,000	1,245,000	1,202,000
Accumulated Other Comprehensive Income	(157,000)	(155,000)	(493,000)	(479,000)
Retained Earnings	432,000	250,000	583,000	1,048,000
Total Common Shareholders' Equity	321,000	328,000	220,000	556,000
Minority Interests and Other	161,000	164,000	168,000	173,000
Total Shareholders' Equity	482,000	492,000	388,000	729,000
Total Liabilities and Shareholders' Equity	5,561,000	5,751,000	5,945,000	6,158,000

In thousands, USD
	FY 2025	FY 2024	FY 2023	FY 2022
Net Income	824,000	292,000	161,000	471,000
Depreciation & Amortization	219,000	235,000	236,000	224,000
Share-Based Compensation Expense	81,000	74,000	73,000	52,000
Other Adjustments	68,000	335,000	334,000	138,000
Changes in Trade Receivables	(145,000)	(34,000)	(13,000)	(84,000)
Changes in Inventories	63,000	55,000	58,000	(18,000)
Changes in Accounts Payable	(124,000)	(140,000)	157,000	(47,000)
Changes in Income Taxes Payable	2,000	(147,000)	152,000	35,000
Changes in Other Operating Activities	(7,000)	25,000	0	15,000
Cash from Operating Activities	981,000	695,000	1,158,000	786,000
Capital Expenditure	(220,000)	(212,000)	(228,000)	(251,000)
Proceeds from Business Divestments	128,000	17,000	—	—
Other Investing Activities	(2,000)	20,000	5,000	22,000
Cash from Investing Activities	(94,000)	(175,000)	(223,000)	(229,000)
Issuance of Short-Term Debt	—	(45,000)	(188,000)	237,000
Net Issuance / (Repayments) of Short-Term Debt	—	(45,000)	(188,000)	237,000
Issuance of Long-Term Debt	—	—	—	1,085,000
Repayments of Long-Term Debt	—	—	—	(1,405,000)
Net Issuance / (Repayments) of Long-Term Debt	—	—	—	(320,000)
Issuance of Common Shares	26,000	1,000	33,000	5,000
Repurchases of Common Shares	(332,000)	—	—	(25,000)
Net Issuance / (Repurchases) of Common Shares	(306,000)	1,000	33,000	(20,000)
Common Share Dividends Paid	(602,000)	(595,000)	(583,000)	(571,000)
Other Financing Activities	(16,000)	(16,000)	(15,000)	(15,000)
Cash from Financing Activities	(924,000)	(655,000)	(753,000)	(689,000)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	—	(26,000)	—	(6,000)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash	(37,000)	(161,000)	182,000	(138,000)

Key metrics

$14.73B

Market Cap

18.42x

P/E

2.07x

P/S

13.55x

EV/EBITDA

169.2%

Return on Equity

20.0%

Return on Invested Capital

0.84x

Current Ratio

4.1%

Dividend Yield

10.7%

Free Cash Flow Margin

Quarterly trend

Quarter	Revenue	YoY growth	Operating margin	Operating income
Q3 2026	$1.67B	+0.1%	17.3%	$289M
Q2 2026	$1.67B	+-0.8%	14.4%	$241M
Q1 2026	$1.43B	+-18.9%	8.7%	$125M
Q4 2025	$1.99B	+4.5%	21.4%	$425M
Q3 2025	$1.67B	—	14.6%	$243M
Q2 2025	$1.69B	—	14.0%	$236M
Q1 2025	$1.76B	—	10.0%	$176M
Q4 2024	$1.90B	—	16.7%	$317M

Margins

45.2%

Gross margin

15.2%

Operating margin

11.6%

Net margin

SourceCompany financial filings (income statement, balance sheet, cash flow) Last updated2026-06-18

Snapshot

Financial statements

Key metrics

Quarterly trend

Margins

More on Clorox Company (The)

See how VectorShift works for your firm